Inogen Research Development from 2010 to 2026

INGN Stock  USD 5.90  0.08  1.37%   
Inogen Research Development yearly trend continues to be very stable with very little volatility. Research Development is likely to grow to about 26.1 M this year. During the period from 2010 to 2026, Inogen Research Development quarterly data regression pattern had sample variance of 81.6 T and median of  7,029,000. View All Fundamentals
 
Research Development  
First Reported
2012-09-30
Previous Quarter
5.2 M
Current Value
4.8 M
Quarterly Volatility
1.9 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Inogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.5 M, Interest Expense of 6.4 M or Selling General Administrative of 87.6 M, as well as many indicators such as Price To Sales Ratio of 0.71, Dividend Yield of 0.0 or PTB Ratio of 1.36. Inogen financial statements analysis is a perfect complement when working with Inogen Valuation or Volatility modules.
  
Build AI portfolio with Inogen Stock
Check out the analysis of Inogen Correlation against competitors.
Evaluating Inogen's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Inogen Inc's fundamental strength.

Latest Inogen's Research Development Growth Pattern

Below is the plot of the Research Development of Inogen Inc over the last few years. It is Inogen's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inogen's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Inogen Research Development Regression Statistics

Arithmetic Mean11,073,269
Geometric Mean7,386,468
Coefficient Of Variation81.58
Mean Deviation8,056,670
Median7,029,000
Standard Deviation9,033,156
Sample Variance81.6T
Range24.3M
R-Value0.96
Mean Square Error7.1T
R-Squared0.92
Slope1,713,848
Total Sum of Squares1305.6T

Inogen Research Development History

202626.1 M
202524.9 M
202421.6 M
202320.8 M
202221.9 M
202116.6 M
202014.1 M

About Inogen Financial Statements

Inogen investors utilize fundamental indicators, such as Research Development, to predict how Inogen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development24.9 M26.1 M

Pair Trading with Inogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inogen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Inogen Stock

  0.73OTC Ocumetics Technology CorpPairCorr
  0.61TFX Teleflex IncorporatedPairCorr

Moving against Inogen Stock

  0.8GMED Globus MedicalPairCorr
  0.76GKOS Glaukos CorpPairCorr
  0.64FPH Fisher Paykel HealthcarePairCorr
  0.63BFLY Butterfly NetworkPairCorr
  0.61IMR Imricor Medical SystemsPairCorr
The ability to find closely correlated positions to Inogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inogen Inc to buy it.
The correlation of Inogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock:
Check out the analysis of Inogen Correlation against competitors.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Will Health Care Equipment & Supplies sector continue expanding? Could Inogen diversify its offerings? Factors like these will boost the valuation of Inogen. Market participants price Inogen higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Inogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.873
Earnings Share
(1.00)
Revenue Per Share
13.467
Quarterly Revenue Growth
0.04
Return On Assets
(0.06)
Investors evaluate Inogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Inogen's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Inogen's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Inogen's market price signifies the transaction level at which participants voluntarily complete trades.